Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

1.
2.

The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.

Lenzner C, Morgenthaler NG.

Thyroid. 2003 Dec;13(12):1153-61.

PMID:
14751037
[PubMed - indexed for MEDLINE]
3.

Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor.

Schwarz-Lauer L, Chazenbalk GD, Mclachlan SM, Ochi Y, Nagayama Y, Rapoport B.

Thyroid. 2002 Feb;12(2):115-20.

PMID:
11916280
[PubMed - indexed for MEDLINE]
4.

TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis.

Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, Ishii J, Katayama S, Ito K.

Clin Endocrinol (Oxf). 1998 Apr;48(4):445-53.

PMID:
9640411
[PubMed - indexed for MEDLINE]
5.

A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity.

Li Y, Kim J, Diana T, Klasen R, Olivo PD, Kahaly GJ.

Clin Exp Immunol. 2013 Sep;173(3):390-7. doi: 10.1111/cei.12129.

PMID:
23647395
[PubMed - indexed for MEDLINE]
6.

A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.

Hovens GC, Buiting AM, Karperien M, Ballieux BE, van der Pluijm G, Pereira AM, Romijn JA, Smit JW.

Clin Endocrinol (Oxf). 2006 Apr;64(4):429-35.

PMID:
16584516
[PubMed - indexed for MEDLINE]
7.

Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.

Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.

Acta Med Austriaca. 1996;23(1-2):52-6.

PMID:
8767515
[PubMed - indexed for MEDLINE]
8.

Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.

Ueta Y, Fukui H, Murakami H, Yamanouchi Y, Yamamoto R, Murao A, Santou Y, Taniguchi S, Mitani Y, Shigemasa C.

Thyroid. 1999 Feb;9(2):179-82.

PMID:
10090319
[PubMed - indexed for MEDLINE]
9.
10.

Clinical applications of TSH receptor antibodies in thyroid diseases.

Cho BY.

J Korean Med Sci. 2002 Jun;17(3):293-301. Review.

PMID:
12068130
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.

Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.

Thyroid. 2000 Oct;10(10):891-6.

PMID:
11081255
[PubMed - indexed for MEDLINE]
13.

A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.

Giuliani C, Cerrone D, Harii N, Thornton M, Kohn LD, Dagia NM, Fiore E, Bucci I, Chamblin T, Vitti P, Monaco F, Napolitano G.

J Clin Endocrinol Metab. 2012 Jul;97(7):E1106-15. doi: 10.1210/jc.2011-2893. Epub 2012 Apr 10.

PMID:
22496495
[PubMed - indexed for MEDLINE]
14.

Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases.

Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, Nagasawa Y, Asawa T.

Clin Endocrinol (Oxf). 1990 Dec;33(6):687-98.

PMID:
1982861
[PubMed - indexed for MEDLINE]
16.

A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.

Ochi Y, Kajita Y, Hachiya T, Hamaoki M.

Med Hypotheses. 2012 Jun;78(6):781-6. doi: 10.1016/j.mehy.2012.03.006. Epub 2012 Apr 1.

PMID:
22472575
[PubMed - indexed for MEDLINE]
17.

Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.

Akamizu T, Kohn LD, Hiratani H, Saijo M, Tahara K, Nakao K.

J Clin Endocrinol Metab. 2000 Jun;85(6):2116-21.

PMID:
10852437
[PubMed - indexed for MEDLINE]
18.

Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.

Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG.

Horm Metab Res. 2005 Dec;37(12):741-4.

PMID:
16372227
[PubMed - indexed for MEDLINE]
19.

The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.

McLachlan SM, Nagayama Y, Pichurin PN, Mizutori Y, Chen CR, Misharin A, Aliesky HA, Rapoport B.

Endocrinology. 2007 Dec;148(12):5724-33. Epub 2007 Sep 6.

PMID:
17823263
[PubMed - indexed for MEDLINE]
20.

Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.

Yamano Y, Takamatsu J, Sakane S, Hirai K, Kuma K, Ohsawa N.

Thyroid. 1999 Aug;9(8):769-73.

PMID:
10482368
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk